Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Correction to Modifying Self-Assembled Peptide Cages To Control Internalization into Mammalian Cells.

Beesley JL, Baum HE, Hodgson LR, Verkade P, Banting GS, Woolfson DN.

Nano Lett. 2019 May 8;19(5):3386. doi: 10.1021/acs.nanolett.9b01133. Epub 2019 Apr 11. No abstract available.

PMID:
30973742
2.

Modifying Self-Assembled Peptide Cages To Control Internalization into Mammalian Cells.

Beesley JL, Baum HE, Hodgson LR, Verkade P, Banting GS, Woolfson DN.

Nano Lett. 2018 Sep 12;18(9):5933-5937. doi: 10.1021/acs.nanolett.8b02633. Epub 2018 Aug 8. Erratum in: Nano Lett. 2019 May 8;19(5):3386.

PMID:
30084257
3.

The European Federation of Clinical Chemistry and Laboratory Medicine syllabus for postgraduate education and training for Specialists in Laboratory Medicine: version 5 - 2018.

Jassam N, Lake J, Dabrowska M, Queralto J, Rizos D, Lichtinghagen R, Baum H, Ceriotti F, O'Mullane J, Homšak E, Charilaou C, Ohlson M, Rako I, Vitkus D, Kovac G, Verschuure P, Racek J, Chifiriuc MC, Wieringa G.

Clin Chem Lab Med. 2018 Oct 25;56(11):1846-1863. doi: 10.1515/cclm-2018-0344.

4.

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, Watts GF, Borén J, Baum H, Bruckert E, Catapano A, Descamps OS, von Eckardstein A, Kamstrup PR, Kolovou G, Kronenberg F, Langsted A, Pulkki K, Rifai N, Sypniewska G, Wiklund O, Nordestgaard BG; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14.

5.

Clinical Excellence in Endocrinology.

Baum HBA.

J Clin Endocrinol Metab. 2018 May 3. doi: 10.1210/jc.2018-00916. [Epub ahead of print]

PMID:
29733361
6.
7.

Excess ω-6 fatty acids influx in aging drives metabolic dysregulation, electrocardiographic alterations, and low-grade chronic inflammation.

Kain V, Ingle KA, Kachman M, Baum H, Shanmugam G, Rajasekaran NS, Young ME, Halade GV.

Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H160-H169. doi: 10.1152/ajpheart.00297.2017. Epub 2017 Oct 6.

8.

Correction: Dissection of TALE-dependent gene activation reveals that they induce transcription cooperatively and in both orientations.

Streubel J, Baum H, Grau J, Stuttmann J, Boch J.

PLoS One. 2017 Apr 6;12(4):e0175653. doi: 10.1371/journal.pone.0175653. eCollection 2017.

9.

Dissection of TALE-dependent gene activation reveals that they induce transcription cooperatively and in both orientations.

Streubel J, Baum H, Grau J, Stuttmann J, Boch J.

PLoS One. 2017 Mar 16;12(3):e0173580. doi: 10.1371/journal.pone.0173580. eCollection 2017. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175653. Stuttman J [corrected to Stuttmann J].

10.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

11.

Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Borén J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem. 2016 Jul;62(7):930-46. doi: 10.1373/clinchem.2016.258897. Epub 2016 May 27.

12.

Ectopic ACTH Production Leading to Diagnosis of Underlying Medullary Thyroid Carcinoma.

Matheny LN, Wilson JR, Baum HB.

J Investig Med High Impact Case Rep. 2016 Apr 8;4(2):2324709616643989. doi: 10.1177/2324709616643989. eCollection 2016 Apr-Jun.

13.

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Borén J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative.

Eur Heart J. 2016 Jul 1;37(25):1944-58. doi: 10.1093/eurheartj/ehw152. Epub 2016 Apr 26.

14.

Patient-adapted, specific activation of HIV-1 by customized TAL effectors (TALEs), a proof of principle study.

Geissler R, Hauber I, Funk N, Richter A, Behrens M, Renner I, Chemnitz J, Hofmann-Sieber H, Baum H, van Lunzen J, Boch J, Hauber J, Behrens SE.

Virology. 2015 Dec;486:248-54. doi: 10.1016/j.virol.2015.09.018. Epub 2015 Oct 27.

15.

ICSH guidelines for the verification and performance of automated cell counters for body fluids.

Bourner G, De la Salle B, George T, Tabe Y, Baum H, Culp N, Keng TB; International Committee for Standardization in Hematology (ICSH).

Int J Lab Hematol. 2014 Dec;36(6):598-612. doi: 10.1111/ijlh.12196. Epub 2014 Mar 14.

PMID:
24628711
16.

Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group.

Langlois MR, Descamps OS, van der Laarse A, Weykamp C, Baum H, Pulkki K, von Eckardstein A, De Bacquer D, Borén J, Wiklund O, Laitinen P, Oosterhuis WP, Cobbaert C; EAS-EFLM Collaborative Project.

Atherosclerosis. 2014 Mar;233(1):83-90. doi: 10.1016/j.atherosclerosis.2013.12.016. Epub 2014 Jan 4.

PMID:
24529127
17.

Continuing improvement in type 2 diabetes care through performance-based evaluations.

Baum HB, Cagliero E, Berry CA, Mencia WA, Stowell SA, Miller SC.

J Prim Care Community Health. 2014 Apr 1;5(2):107-11. doi: 10.1177/2150131913518438. Epub 2014 Jan 21.

PMID:
24451654
18.

Impact of Performance-Improvement Strategies on the Clinical Care and Outcomes of Patients With Type 2 Diabetes.

Stowell SA, Baum HB, Berry CA, Perri BR, King L, Mijanovich T, Albert S, Miller SC.

Clin Diabetes. 2014 Jan;32(1):18-25. doi: 10.2337/diaclin.32.1.18. No abstract available.

19.

Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy.

Plummer MS, Cornicelli J, Roark H, Skalitzky DJ, Stankovic CJ, Bove S, Pandit J, Goodman A, Hicks J, Shahripour A, Beidler D, Lu XK, Sanchez B, Whitehead C, Sarver R, Braden T, Gowan R, Shen XQ, Welch K, Ogden A, Sadagopan N, Baum H, Miller H, Banotai C, Spessard C, Lightle S.

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3443-7. doi: 10.1016/j.bmcl.2013.03.082. Epub 2013 Mar 29.

PMID:
23597790
20.

Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors.

Plummer MS, Cornicelli J, Roark H, Skalitzky DJ, Stankovic CJ, Bove S, Pandit J, Goodman A, Hicks J, Shahripour A, Beidler D, Lu XK, Sanchez B, Whitehead C, Sarver R, Braden T, Gowan R, Shen XQ, Welch K, Ogden A, Sadagopan N, Baum H, Miller H, Banotai C, Spessard C, Lightle S.

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3438-42. doi: 10.1016/j.bmcl.2013.03.072. Epub 2013 Mar 28.

PMID:
23582272
21.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).

Hammerer-Lercher A, Collinson P, van Dieijen-Visser MP, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem Lab Med. 2013 Jun;51(6):1301-6. doi: 10.1515/cclm-2012-0510.

PMID:
23334056
22.

Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation.

Aakre KM, Langlois MR, Watine J, Barth JH, Baum H, Collinson P, Laitinen P, Oosterhuis WP.

Clin Chem Lab Med. 2013 Jun;51(6):1217-26. Review.

PMID:
23037517
23.

The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine: version 4--2012.

Wieringa G, Zerah S, Jansen R, Simundic AM, Queralto J, Solnica B, Gruson D, Tomberg K, Riittinen L, Baum H, Brochet JP, Buhagiar G, Charilaou C, Grigore C, Johnsen AH, Kappelmayer J, Majkic-Singh N, Nubile G, O'Mullane J, Opp M, Pupure S, Racek J, Reguengo H, Rizos D, Rogic D, Špaňár J, Štrakl G, Szekeres T, Tzatchev K, Vitkus D, Wallemacq P, Wallinder H; European Communities Confederation of Clinical Chemistry.

Clin Chem Lab Med. 2012 Aug;50(8):1317-28.

PMID:
23035263
24.

[Remission of incomplete paraplegia after thoracic stent graft implantation. Case report and review of the literature].

Jacobs A, Jahnke T, Baum H, Brammer H, Hansen HC.

Nervenarzt. 2012 Apr;83(4):506-9. doi: 10.1007/s00115-011-3406-4. Review. German. No abstract available.

PMID:
22525972
25.

N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial.

Luchner A, Möckel M, Spanuth E, Möcks J, Peetz D, Baum H, Spes C, Wrede CE, Vollert J, Müller R, Katus H, Giannitsis E.

Eur J Heart Fail. 2012 Mar;14(3):259-67. doi: 10.1093/eurjhf/hfr171. Epub 2012 Jan 20.

26.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

27.

DNA identification in mass fatality incidents.

Weedn VW, Baum HJ.

Am J Forensic Med Pathol. 2011 Dec;32(4):393-7. doi: 10.1097/PAF.0b013e31822ed56e. Review.

PMID:
21897189
28.

Autoimmunity and environment: am I at risk?

Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP.

Clin Rev Allergy Immunol. 2012 Apr;42(2):199-212. doi: 10.1007/s12016-011-8259-x. Review.

PMID:
21337133
29.

The role of E. coli infection in the pathogenesis of primary biliary cirrhosis.

Bogdanos DP, Baum H, Vergani D, Burroughs AK.

Dis Markers. 2010;29(6):301-11. doi: 10.3233/DMA-2010-0745. Review.

30.

The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: guide to the Register, version 3-2010.

McMurray J, Zérah S, Hallworth M, Schuff-Werner P, Haushofer A, Szekeres T, Wallemacq P, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O'Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Jansen R, Solnica B, Reguengo H, Grigore C, Spanár J, Strakl G, Queralto J, Wallinder H, Wieringa G.

Clin Chem Lab Med. 2010 Jul;48(7):999-1008. doi: 10.1515/CCLM.2010.223.

PMID:
20406129
31.

[The European Register of specialists in clinical chemistry and laboratory medicine: code of conduct Version 2-2008].

McMurray J, Zerah S, Hallworth M, Koeller U, Blaton V, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O'Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Huisman W, Solnica B, Reguengo H, Grigore C, Spanár J, Strakl G, Queralto J, Wallinder H, Schuff-Werner P.

Ann Biol Clin (Paris). 2010 Jan-Feb;68(1):121-5. doi: 10.1684/abc.2010.0408. French. No abstract available.

32.

A novel methodology to estimate the evolution of construction waste in construction sites.

Katz A, Baum H.

Waste Manag. 2011 Feb;31(2):353-8. doi: 10.1016/j.wasman.2010.01.008. Epub 2010 Jan 27.

PMID:
20106651
33.

The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Code of Conduct, Version 2--2008.

McMurray J, Zerah S, Hallworth M, Koeller U, Blaton V, Tzatchev K, Charilaou C, Racek J, Johnsen A, Tomberg K, Harmoinen A, Baum H, Rizos D, Kappelmayer J, O'Mullane J, Nubile G, Pupure S, Kucinskiene Z, Opp M, Huisman W, Solnica B, Reguengo H, Grigore C, Spanár J, Strakl G, Queralto J, Wallinder H, Schuff-Werner P.

Clin Chem Lab Med. 2009;47(3):372-5.

PMID:
19676151
34.

Validation of testing and interpretation protocols for low template DNA samples using AmpFlSTR Identifiler.

Caragine T, Mikulasovich R, Tamariz J, Bajda E, Sebestyen J, Baum H, Prinz M.

Croat Med J. 2009 Jun;50(3):250-67.

35.

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen P.

Clin Chem Lab Med. 2009;47(2):227-34. doi: 10.1515/CCLM.2009.044.

PMID:
19099527
36.

Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood.

Giannitsis E, Baum H, Bertsch T, Juchum M, Müller-Bardorf M, Jørgensen B, Böhmer A, Rebmann M, Schäffler J, Schwab M, Zerback R.

Clin Chem Lab Med. 2008;46(5):630-8.

PMID:
18839464
37.

[Efficient and rational laboratory diagnostics in otolaryngology].

Cuenca S, Schulz C, Mössmer G, Baum H, Luppa PB.

HNO. 2008 Sep;56(9):855-73. doi: 10.1007/s00106-008-1760-8. German.

PMID:
18704349
38.

Comparison of 2 interventions for liquid aspiration on pneumonia incidence: a randomized trial.

Robbins J, Gensler G, Hind J, Logemann JA, Lindblad AS, Brandt D, Baum H, Lilienfeld D, Kosek S, Lundy D, Dikeman K, Kazandjian M, Gramigna GD, McGarvey-Toler S, Miller Gardner PJ.

Ann Intern Med. 2008 Apr 1;148(7):509-18. Erratum in: Ann Intern Med. 2008 May 6;148(9):715.

39.

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

Collinson P, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen PH.

Clin Chem. 2008 Feb;54(2):448-9. doi: 10.1373/clinchem.2007.097501. No abstract available.

40.

Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.

Maibaum J, Stutz S, Göschke R, Rigollier P, Yamaguchi Y, Cumin F, Rahuel J, Baum HP, Cohen NC, Schnell CR, Fuhrer W, Gruetter MG, Schilling W, Wood JM.

J Med Chem. 2007 Oct 4;50(20):4832-44. Epub 2007 Sep 8.

PMID:
17824680
41.

Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.

Göschke R, Stutz S, Rasetti V, Cohen NC, Rahuel J, Rigollier P, Baum HP, Forgiarini P, Schnell CR, Wagner T, Gruetter MG, Fuhrer W, Schilling W, Cumin F, Wood JM, Maibaum J.

J Med Chem. 2007 Oct 4;50(20):4818-31. Epub 2007 Sep 8.

PMID:
17824679
42.

N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.

Deur C, Agrawal AK, Baum H, Booth J, Bove S, Brieland J, Bunker A, Connolly C, Cornicelli J, Dumin J, Finzel B, Gan X, Guppy S, Kamilar G, Kilgore K, Lee P, Loi CM, Lou Z, Morris M, Philippe L, Przybranowski S, Riley F, Samas B, Sanchez B, Tecle H, Wang Z, Welch K, Wilson M, Yates K.

Bioorg Med Chem Lett. 2007 Aug 15;17(16):4599-603. Epub 2007 May 31.

PMID:
17562362
43.

213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice.

Beck R, Seidl C, Pfost B, Morgenstern A, Bruchertseifer F, Baum H, Schwaiger M, Senekowitsch-Schmidtke R.

Cancer Sci. 2007 Aug;98(8):1215-22. Epub 2007 Jun 11.

44.

Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis.

Rigopoulou EI, Bogdanos DP, Liaskos C, Koutsoumpas A, Baum H, Vergani D, Dalekos GN.

Clin Chim Acta. 2007 May 1;380(1-2):118-21. Epub 2007 Feb 1.

PMID:
17321509
45.

Challenges in the design and conduct of a randomized study of two interventions for liquid aspiration.

Brandt DK, Hind JA, Robbins J, Lindblad AS, Gensler G, Gill G, Baum H, Lilienfeld D, Logemann JA; Communication Sciences and Disorders Clinical Trials Research Group.

Clin Trials. 2006;3(5):457-68.

PMID:
17060219
46.

Operational hurricane intensity forecasting.

Baum HR, Fendell F.

Science. 2006 Oct 20;314(5798):419. No abstract available.

PMID:
17053129
47.

Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis.

Bogdanos DP, Koutsoumpas A, Baum H, Vergani D.

Dig Liver Dis. 2006 Oct;38(10):781-2; author reply 782-3. Epub 2006 Jul 25. No abstract available.

PMID:
16870516
48.

EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 - 2005.

Zerah S, McMurray J, Bousquet B, Baum H, Beastall GH, Blaton V, Cals MJ, Duchassaing D, Gaudeau-Toussaint MF, Harmoinen A, Hoffmann H, Jansen RT, Kenny D, Kohse KP, Köller U, Gobert JG, Linget C, Lund E, Nubile G, Opp M, Pazzagli M, Pinon G, Queralto JM, Reguengo H, Rizos D, Szekeres T, Vidaud M, Wallinder H; European Communities of Clinical Chemistry, EC4 Register Commission.

Clin Chem Lab Med. 2006;44(1):110-20.

PMID:
16375596
49.

A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.

Bogdanos DP, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D.

Clin Dev Immunol. 2005 Sep;12(3):217-24.

50.

Epidemiology. DNA identifications after the 9/11 World Trade Center attack.

Biesecker LG, Bailey-Wilson JE, Ballantyne J, Baum H, Bieber FR, Brenner C, Budowle B, Butler JM, Carmody G, Conneally PM, Duceman B, Eisenberg A, Forman L, Kidd KK, Leclair B, Niezgoda S, Parsons TJ, Pugh E, Shaler R, Sherry ST, Sozer A, Walsh A.

Science. 2005 Nov 18;310(5751):1122-3.

PMID:
16293742

Supplemental Content

Support Center